{
    "title": "Ribena and Lucozade snapped up by Japanese giant that owns Orangina and Schweppes in \u00a31bn deal",
    "url": "https://www.dailymail.co.uk/money/markets/article-2413053/GSK-ready-sell-Ribena-Lucozade-Japanese-rival-Suntory.html",
    "date": "2013-09-05",
    "keywords": [
        "gsk",
        "suntory",
        "market",
        "firm",
        "melanoma",
        "vaccine",
        "ribena",
        "lucozade",
        "deal",
        "capital",
        "consumer",
        "year",
        "orangina",
        "roger",
        "baird",
        "gmt",
        "september",
        "view",
        "glaxosmithkline",
        "dealsuntory",
        "number",
        "equity",
        "sale",
        "auction",
        "monthbuyout",
        "blackstone",
        "lion",
        "cinven",
        "agreement",
        "maker",
        "april",
        "health",
        "division",
        "uk",
        "presence",
        "unit",
        "pixmania",
        "billionpound",
        "blockbuster",
        "treatment",
        "trial",
        "survival",
        "stage",
        "testsgsk",
        "subsection",
        "drug",
        "lung",
        "cancer",
        "area",
        "worldwide",
        "skin",
        "cancergsk",
        "magea3",
        "analyst",
        "savvas",
        "neophytou",
        "panmure",
        "gordon",
        "result",
        "disappointing",
        "recommendation",
        "stockgsk",
        "communist",
        "state",
        "executive",
        "sir",
        "staff",
        "behaviour"
    ],
    "category": [
        "money",
        "markets"
    ]
}